With retatrutide trials showing losses near 29%, doctors quoted by Medscape describe when weight loss may be going too far and lost strength calls for a rethink.
Recap by typeshit. Full story at Medscape.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
The actress has spoken out with a warning about Ozempic. Only a short link is given, with no details on what she said.
Trials showed low rates, while FAERS and EudraVigilance logged a wider range of events. The Warwick-linked authors call for standardized reporting and close monitoring.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Loading…